Crane Co. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Crane Co. on October 24, 2016. The filing primarily addresses the Company's results of operations for the quarter ended September 30, 2016 (referenced in Item 2.02) and provides a detailed update on asbestos liability claims and costs (Item 8.01). The Company is incorporated in Delaware and maintains its principal executive offices in Stamford, CT.
Key Financial Metrics: Asbestos Liability
The filing does not provide consolidated revenue, profit, or cash flow figures for the quarter; these are contained in the referenced press release (Exhibit 99.1). However, specific financial data regarding asbestos litigation is provided:
- Total Asbestos Liability: $487 million as of September 30, 2016 (down from $894 million recorded in 2011).
- Current Portion of Liability: $75 million (estimated costs to be paid within the next 12 months).
- Insurance Receivable Asset: $112 million as of September 30, 2016 (representing probable reimbursements).
- Cumulative Resolved Claims: Approximately 123,000 claims resolved through September 30, 2016, with total settlement costs of approximately $471 million.
- Average Settlement Cost: Approximately $3,800 per resolved claim cumulatively.
Material Changes and Activity (Nine Months Ended Sept 30, 2016)
The following table details the activity and costs associated with asbestos claims for the nine-month period ended September 30, 2016, compared to the prior year:
| Item (in millions) | 2016 | 2015 |
|---|---|---|
| Claims Activity | ||
| Beginning Claims | 41,090 | 47,507 |
| New Claims | 2,239 | 1,960 |
| Settlements | (728) | (768) |
| Dismissals | (6,151) | (6,987) |
| Ending Claims | 36,450 | 41,712 |
| Costs Incurred (Pre-tax) | ||
| Settlement/Indemnity Costs | $25.3 | $21.3 |
| Defense Costs | $32.2 | $31.2 |
| Total Costs Incurred | $57.5 | $52.5 |
| Cash Payments (Net of Insurance) | ||
| Pre-tax Cash Payments | $41.5 | $36.2 |
Material Changes: The number of pending claims decreased by approximately 5,262 year-over-year. Total costs incurred increased by $5.0 million, driven by higher settlement costs ($4.0 million increase) and slightly higher defense costs ($1.0 million increase). Net cash payments increased by $5.3 million.
Outlook, Risks, and Significant Legal Developments
Liability Estimate Stability: Management determined that no change to the asbestos liability estimate was warranted for the period ended September 30, 2016. The estimate covers claims projected through 2021. The Company does not believe costs beyond 2021 can be reasonably estimated.
Significant Verdicts and Appeals:
- Ronald Dummitt (NY): Judgment affirmed by NY Court of Appeals on June 28, 2016. Company paid $6.6 million (with interest) in Q3 2016.
- Gerald Suttner (NY): Judgment affirmed by NY Court of Appeals on June 28, 2016. Company paid $0.2 million (with interest) in Q3 2016.
- Ivo Peraica (NY): Appellate Division reduced damages to $4.25 million ($1.94 million after offsets). Plaintiff may accept or request a new trial on damages.
- Sweberg & Hackshaw (NY): Appellate Division reduced Sweberg damages to $9.5 million ($4.73 million after offsets) and Hackshaw to $3 million ($0 after offsets). Plaintiffs may accept or request new trials.
- Richard DeLisle (FL): Florida Court of Appeals reversed judgment in favor of the Company on September 14, 2016. Plaintiff seeking rehearing.
- James Poage (MO): $10.8 million judgment entered; Company is pursuing appeal.
- George Coulbourn (AZ): $6.8 million judgment entered; Company is pursuing appeal.
Risks and Uncertainties: The ultimate exposure is subject to significant uncertainties regarding the number of future claims, settlement costs, defense costs, and insurance recoveries. The Company notes that while it is probable additional charges will be incurred, amounts beyond 2021 cannot be reasonably estimated. The liability estimate is heavily influenced by mesothelioma claims, which account for approximately 90% of aggregate costs despite being only 8% of pending claims.
Investor Verification Checklist
- Verify the full quarterly financial results (Revenue, Net Income, EPS) in the referenced Exhibit 99.1 (Earnings Press Release), as this 8-K does not contain consolidated operating metrics.
- Monitor the status of the Ivo Peraica and Sweberg/Hackshaw cases in New York, as plaintiffs have the option to request new trials on damages, which could alter the final payout.
- Review the coverage-in-place agreements and policy buyout details to understand the reliability of the $112 million insurance receivable asset.
- Track the James Poage (Missouri) and George Coulbourn (Arizona) appeals, as these represent significant pending judgments ($10.8M and $6.8M respectively) not yet fully resolved.
- Assess the impact of the 25% estimated insurance reimbursement rate on future cash flows, noting that actual reimbursements may vary and decline over time.